4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001209191-23-048967
Chief Scientific Officer gave up 9,525 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| van der Horst Edward Chief Scientific Officer | 2023-02-15 | Shares withheld for taxes | −9,525 | $1.50 | $14,288 | 52,913 | D |
Loading xslF345X05/doc4.xml…